Irritable bowel syndrome is positively related to metabolic syndrome: a population-based cross-sectional study - PubMed (original) (raw)

Yinting Guo et al. PLoS One. 2014.

Abstract

Irritable bowel syndrome is a common gastrointestinal disorder that may affect dietary pattern, food digestion, and nutrient absorption. The nutrition-related factors are closely related to metabolic syndrome, implying that irritable bowel syndrome may be a potential risk factor for metabolic syndrome. However, few epidemiological studies are available which are related to this potential link. The purpose of this study is to determine whether irritable bowel syndrome is related to metabolic syndrome among middle-aged people. We designed a cross-sectional study of 1,096 subjects to evaluate the relationship between irritable bowel syndrome and metabolic syndrome and its components. Diagnosis of irritable bowel syndrome was based on the Japanese version of the Rome III Questionnaire. Metabolic syndrome was defined according to the criteria of the American Heart Association scientific statements of 2009. Dietary consumption was assessed via a validated food frequency questionnaire. Principal-components analysis was used to derive 3 major dietary patterns: "Japanese", "sweets-fruits", and "Izakaya (Japanese Pub) "from 39 food groups. The prevalence of irritable bowel syndrome and metabolic syndrome were 19.4% and 14.6%, respectively. No significant relationship was found between the dietary pattern factor score tertiles and irritable bowel syndrome. After adjustment for potential confounders (including dietary pattern), the odds ratio (95% confidence interval) of having metabolic syndrome and elevated triglycerides for subjects with irritable bowel syndrome as compared with non-irritable bowel syndrome are 2.01(1.13-3.55) and 1.50(1.03-2.18), respectively. Irritable bowel syndrome is significantly related to metabolic syndrome and it components. This study is the first to show that irritable bowel syndrome was significantly related to a higher prevalence of metabolic syndrome and elevated triglycerides among an adult population. The findings suggest that the treatment of irritable bowel syndrome may be a potentially beneficial factor for the prevention of metabolic syndrome. Further study is needed to clarify this association.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: All the authors have no conflicts of interest exists to disclose.

References

    1. Camilleri M (2001) Management of the irritable bowel syndrome. Gastroenterology 120: 652–668. - PubMed
    1. Chang L (2004) Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 Suppl 731–39. - PubMed
    1. Hayes P, Corish C, O'Mahony E, Quigley EM (2013) A dietary survey of patients with irritable bowel syndrome. J Hum Nutr Diet: (in press. doi: 10.1111/jhn.12114). - PubMed
    1. Feinle-Bisset C, Azpiroz F (2013) Dietary lipids and functional gastrointestinal disorders. Am J Gastroenterol 108: 737–747. - PubMed
    1. Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, et al. (2001) Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 63: 108–115. - PubMed

Publication types

MeSH terms

LinkOut - more resources